Radiopharmaceutical developer FluoroPharma Medical has named Dr. Thomas Tulip as president.
Tulip most recently served in leadership roles at Navidea Biopharmaceuticals from 2011-2015, according to FluoroPharma. He has spent more than 25 years in the development and commercialization of radiopharmaceuticals and imaging agents, including positions at Alseres Pharmaceuticals, Lantheus Medical Imaging, Bristol-Myers Squibb, and DuPont, FluoroPharma said.
In his new position at FluoroPharma, Tulip will be responsible for day-to-day operations, with a focus on global product and business development strategies.
